Canadian policies delay patient access to new drugs, says report
This article was originally published in SRA
Executive Summary
Health Canada takes much longer to approve drugs than its US and European counterparts and Canadian drug plans often delay patient access to new medicines even further or deprive patients of drugs altogether, a report by an independent research organisation has found1,2.